Clinical Trial Detail

NCT ID NCT02625623
Title Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors EMD Serono
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Avelumab

Paclitaxel

Irinotecan

Age Groups: adult

No variant requirements are available.